Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. Dezember 2024 10:05 ET | Quelle: TigaTx, Inc.

TigaTx Announces up to $35.5M in Funding from ARPA-H and NIH Awards to Advance First-in-Class Engineered IgA Monoclonal Antibody for Cancer and Infectious Diseases

TigaTx announces up to $35.5M in funding from ARPA-H and NIH awards to advance first-in-class engineered IgA monoclonal antibody for cancer.
18. Dezember 2024 09:00 ET | Quelle: Hyster-Yale Materials Handling

Hyster-Yale announces commitment to Build America, Buy America requirements for electric container handling and forklift equipment

GREENVILLE, N.C., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Hyster-Yale Materials Handling, Inc. announces its plans to fulfill the domestic manufacturing requirements of the Build America, Buy America...
18. Dezember 2024 08:59 ET | Quelle: Novo Nordisk A/S

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed

Bagsværd, Denmark, 18 December 2024 — Today, Novo Nordisk completed its acquisition of three manufacturing sites from Novo Holdings A/S. The completion follows the finalisation of Novo Holdings’...
17. Dezember 2024 04:00 ET | Quelle: FLSmidth A/S

FLSmidth announces changes to Group Executive Management

PRESS RELEASE 17 December 2024, Copenhagen, Denmark FLSmidth announces that Joshua Meyer, President, Mining Service Business Line and Annette Terndrup, Group General Counsel, are stepping down from...
16. Dezember 2024 14:35 ET | Quelle: FastPassCorp A/S

FN6/2024 Ny forventning til årsresultat

NASDAQ FIRST NORTH GROWTH MARKET MEDDELELSE NR. 6/2024 København, den 16. december 2024 FN6/2024 Ny forventning til årsresultat Intern viden: Selskabets bestyrelse meddeler hermed at selskabet...
16. Dezember 2024 07:52 ET | Quelle: Novo Nordisk A/S

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 16 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...
16. Dezember 2024 01:29 ET | Quelle: Novo Nordisk A/S

Novo Nordisk invests DKK 8.5 billion in new production facility in Odense, Denmark

Bagsværd, Denmark, 16 December 2024 – Today, Novo Nordisk announced plans to invest 8.5 billion Danish kroner to establish a completely new production facility in Odense, Denmark. The investment marks...
14. Dezember 2024 00:08 ET | Quelle: Novo Nordisk A/S

Novo Nordisk A/S: The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is cleared to close

Bagsværd, Denmark, 14 December 2024 — As of today, all regulatory closing conditions relating to the review of Novo Holdings A/S’s pending acquisition of Catalent, Inc. (Catalent), including expiry of...
12. Dezember 2024 08:47 ET | Quelle: Novo Nordisk A/S

Novo Nordisk A/S: European regulatory authority adopts positive opinion for an update of the Ozempic® label to reflect risk reduction of kidney disease-related events

Bagsværd, Denmark, 12 December 2024 – Novo Nordisk today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for...
09. Dezember 2024 10:43 ET | Quelle: Novo Nordisk A/S

Novo Nordisk A/S - share repurchase programme

Bagsværd, Denmark, 9 December 2024 – On 11 November 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and...

Vorherige Seite

Nächste Seite